6431 - 6440 of 6456 Results
Title
Year
-
OPENTitle: Perspective: Evolution of Control Variables and Policies for Closed-Loop Deep Brain Stimulation for Parkinson’s Disease Using Bidirectional Deep-Brain-Computer InterfacesJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 353End Page: 353Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.00353Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.00353/pdfCitation Count: 36
-
OPENTitle: Spontaneous changes in brain striatal dopamine synthesis and storage dynamics ex vivo reveal end-product feedback-inhibition of tyrosine hydroxylaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 212Issue #:Start Page: 109058End Page: 109058Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109058Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109058Citation Count: 9
-
OPENTitle: Phenotypical variability in the 6-OHDA mouse model of Parkinson's disease despite consistent and robust nigral lesioningJournal Name: Brain MechanismsPublisher: Elsevier BVVol: 148-150Issue #:Start Page: 202523End Page: 202523Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bramec.2025.202523Best OA location URL: https://doi.org/10.1016/j.bramec.2025.202523Citation Count: 1
-
OPENTitle: Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi PanelJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 4Start Page: 652End Page: 657Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13690Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13690Citation Count: 10
-
OPENTitle: Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on ‘effective’ connectivityJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 4Start Page: 1130End Page: 1144Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu027Best OA location URL: https://academic.oup.com/brain/article-pdf/137/4/1130/13799493/awu027.pdfCitation Count: 220
-
OPENTitle: Two‐Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individualsJournal Name: European Journal of NeurologyPublisher: WileyVol: 30Issue #: 5Start Page: 1281End Page: 1292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.15733Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15733Citation Count: 9
-
OPENTitle: Constructing de Novo H2O2 Signaling via Induced Protein ProximityJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 6Start Page: 1404End Page: 1410Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.5b00170Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4849873Citation Count: 17
-
OPENTitle: Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient ratsJournal Name: Brain, Behavior, & Immunity - HealthPublisher: Elsevier BVVol: 31Issue #:Start Page: 100656End Page: 100656Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbih.2023.100656Best OA location URL: https://doi.org/10.1016/j.bbih.2023.100656Citation Count: 8
-
OPENTitle: Automated Quality Control for Sensor Based Symptom Measurement Performed Outside the LabJournal Name: SensorsPublisher: MDPI AGVol: 18Issue #: 4Start Page: 1215End Page: 1215Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s18041215Best OA location URL: https://www.mdpi.com/1424-8220/18/4/1215/pdf?version=1525348690Citation Count: 26
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 69